Vivek Tomar, PhD, MPharm #RiseToSurviveCancer Profile
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer

@R2SurviveCancer

Followers
994
Following
2K
Statuses
2K

India’s 1st Oncology Patient Research Advocate & Lung Cancer PatientAdvocate | Caregiver | Founder @IndiaALK (1st oncogene patient gp) | Advisor I Guest Faculty

India
Joined September 2017
Don't wanna be here? Send us removal request.
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
20 hours
RT @oncodaily: Co-chairing the Patient Advocacy Workshop on behalf of @LUNGevity - Upal Basu Roy @IASLC @boldcaleb @jillfeldman4 @R2Survive
0
1
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
2 days
RT @Florez_Lab: @R2SurviveCancer @NarjustFlorezMD @KusumVsCancer @jillfeldman4 Hi Dr. Tomar! Thank you for sharing your story! So glad a pi…
0
1
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
2 days
. @Florez_Lab @NarjustFlorezMD: #HearHer has reached India—where most new lung cancer cases are in #women, #young & #nonsmokers. I’ll wear this in memory of my wife @KusumVsCancer, & continue advocating for better #LungCancer care for Women. Thanks @jillfeldman4 for the pin.
Tweet media one
3
8
28
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
2 days
Heartbreaking, yet what an incredible legacy—26 years with Stage IV lung cancer. Wells Whitney's life and advocacy, and research have given hope to millions. His impact will live on. #LCSM #Hope #Research #StageIV #RIP
@LFentonAmbrose
Laurie Fenton Ambrose
2 days
We are deeply saddened by the passing of Wells Whitney, a true champion for the lung cancer community. His dedication, scientific expertise, and personal story inspired so many. His legacy of hope and progress will live on. Our hearts are with his loved ones during this time.
Tweet media one
0
2
3
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
4 days
A letter "Thread of Hope" to my love, @KusumVsCancer , on the day #LungCancer took her from me—six years ago today. The #pain of losing her remains, the #regrets still linger… but so does her #love, her #courage, and the #hope she left behind!
0
3
7
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
4 days
.Lung cancer in never-smokers on the rise: @TheLancet report Non-smokers, especially women, face rising #LungCancer risk in 🇮🇳! #AirPollution is one of the key culprit. We need awareness & action against pollution NOW! #WorldCancerDay @JPNadda
0
1
3
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
5 days
This is not just only a simple, honest request, it’s a lifeline-—it’s a necessity. #EveryLifeMatters #WorldCancerDay
@IndiaAlk
ALKPositiveIndia
5 days
On #WorldCancerDay, we India ALK LungCancer patients urge #affordability & #access in India 🇮🇳 with - @Pfizer & @Roche to cut Lorlatinib & Alectinib prices - @TakedaPharma to restart Brigatinib assistance until sales begin - @nuvalent to bring NVL-655 trial #EveryLifeMatters
0
2
2
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
5 days
RT @SirohiBhawna: We stand united in support of every unique journey - each pts cancer journey is unique and full of hope, resilience, stre…
0
4
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
5 days
RT @urvashi01: Tomorrow is #WorldCancerDay..if there's one thing you do -- read this thread & share it with others. Trust me, it will benef…
0
66
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
6 days
RT @cspramesh: Eggs are amongst the most cost-efficient ways of providing high-quality protein to children who are not averse to eating the…
0
357
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
7 days
Dr Upal Basu Roy, Executive Director of Research at @LUNGevity, raises key unmet needs in the local context at @IASLC #PACLC25. One of the kindest, most supportive in the lung cancer community—a great human being & dear friend, always there, selflessly. Raising needs of LMICs.
Tweet media one
0
4
20
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
7 days
“A candle can light the room” - @jillfeldman4, one of the most passionate patient advocate leader, 16-yr EGFR LC survivor, @EGFRResisters co-founder & a very dear friend, quoting her mother (who also had lung cancer) while sharing the power of #PatientAdvocacy at @IASLC #PACLC25
Tweet media one
1
4
22
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
7 days
With the legend who discovered the #EGFR mutation as well as HLA-A mutation among other innovations - one & only Dr Matthew L. Meyerson @IASLC #PACLC25 in Ghana!! Great discussion on number of research going on in #LungCancer, as well as #research opportunities in #India.
Tweet media one
0
0
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
7 days
0
0
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
8 days
RT @sanjaynagral: Cut & Commissions in Indian Healthcare once again!! Old problem in newer avatars4 ; oldest open secret of Indian healthca…
0
38
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
9 days
Tweet media one
1
0
10
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
14 days
RT @urvashi01: @R2SurviveCancer Totally unreliable, outdated numbers and a huge underestimate in India for sure
0
1
0
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
14 days
When #cancer isn’t a #notifiable disease in India, how reliable are these numbers? Observations suggest a much higher rise. Also, why are we looking on 2018 data in 2025? The world has changed drastically in those 7 years, especially post-COVID.
@KavitaDatt
Kavita Bajeli-Datt
14 days
Cancer cases rose by 35 % between 2008 and 2018 in commonwealth countries: Lancet report @NewIndianXpress @TheMornStandard @MoHFW_INDIA @WHO @WHOSEARO
Tweet media one
Tweet media two
1
2
5
@R2SurviveCancer
Vivek Tomar, PhD, MPharm #RiseToSurviveCancer
14 days
Absolutely! That's why conducting clinical trials across diverse regions globally (including LMICs)—not just in a few (HIC) countries—is critical. #Diversity #clinicaltrials
@JFreemanDaily
Janet Freeman-Daily
14 days
DEI is not the same as diversity in clinical trials. Diversity in clinical trials aims to test new drugs in a wide variety of people, because response to some medicines can vary by gender, age, ethnicity, and genetics.
0
0
2